Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2025-12-29 @ 12:21 PM
Study NCT ID:
NCT05109728
Status:
RECRUITING
Last Update Posted:
2025-12-02
First Post:
2021-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-10
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-27
First Submit QC Date:
None
Study First Post Date:
2021-11-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-28
Last Update Post Date:
2025-12-02
Last Update Post Date Type:
ESTIMATED